L型/T型钙通道阻滞剂联合用药：已准备好投入临床应用。 - Suppr

Suppr

超能文献

Combined L-/T-type calcium channel blockers: ready for prime time.

作者信息

Ge Wei, Ren Jun

出版信息

Hypertension. 2009 Apr;53(4):592-4. doi: 10.1161/HYPERTENSIONAHA.108.127548. Epub 2009 Feb 23.

DOI:10.1161/HYPERTENSIONAHA.108.127548

PMID:19237678

Abstract

摘要

相似文献

Combined L-/T-type calcium channel blockers: ready for prime time.

Hypertension. 2009 Apr;53(4):592-4. doi: 10.1161/HYPERTENSIONAHA.108.127548. Epub 2009 Feb 23.

Is combined L- and T-channel blockade better than L-channel blockade in therapy?

Hypertension. 2009 Jul;54(1):e3; author reply e4. doi: 10.1161/HYPERTENSIONAHA.109.133504. Epub 2009 May 11.

Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.

Acta Physiol (Oxf). 2013 Apr;207(4):690-9. doi: 10.1111/apha.12070. Epub 2013 Feb 21.

[Renal protective action of T-, L-, and N-type Ca channel blockers].

Nihon Rinsho. 2004 Mar;62 Suppl 3:654-61.

Ca2+ channel subtypes and pharmacology in the kidney.

Circ Res. 2007 Feb 16;100(3):342-53. doi: 10.1161/01.RES.0000256155.31133.49.

The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.

J Pharmacol Exp Ther. 2008 Jun;325(3):723-31. doi: 10.1124/jpet.107.133892. Epub 2008 Mar 7.

[Molecular effects of new calcium antagonists: is the principle of parcimony out of place?].

Ann Cardiol Angeiol (Paris). 2008 Jun;57(3):166-73. doi: 10.1016/j.ancard.2008.02.019. Epub 2008 Jun 4.

Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade.

Hypertension. 2009 Apr;53(4):654-60. doi: 10.1161/HYPERTENSIONAHA.108.125831. Epub 2009 Feb 23.

Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2.

Circ Res. 2006 Jan 6;98(1):105-10. doi: 10.1161/01.RES.0000197851.11031.9c. Epub 2005 Nov 23.

Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature.

Hypertension. 2011 Sep;58(3):464-70. doi: 10.1161/HYPERTENSIONAHA.111.170845. Epub 2011 Jul 25.

引用本文的文献

T-type calcium channels as therapeutic targets in essential tremor and Parkinson's disease.

Ann Clin Transl Neurol. 2023 Apr;10(4):462-483. doi: 10.1002/acn3.51735. Epub 2023 Feb 4.

Cerebrovascular and neurological perspectives on adrenoceptor and calcium channel modulating pharmacotherapies.

J Cereb Blood Flow Metab. 2021 Apr;41(4):693-706. doi: 10.1177/0271678X20972869. Epub 2020 Nov 19.

Ion Channels in Glioma Malignancy.

Rev Physiol Biochem Pharmacol. 2021;181:223-267. doi: 10.1007/112_2020_44.

The Gomez' equations and renal hemodynamic function in kidney disease research.

Am J Physiol Renal Physiol. 2016 Nov;311(5):F967-F975. doi: 10.1152/ajprenal.00415.2016. Epub 2016 Sep 7.

T-type calcium channel blockers as neuroprotective agents.

Pflugers Arch. 2014 Apr;466(4):757-65. doi: 10.1007/s00424-014-1454-x. Epub 2014 Feb 25.

Effect of an L- and T-type calcium channel blocker on 24-hour systolic blood pressure and heart rate in hypertensive patients.

Korean Circ J. 2012 Apr;42(4):231-8. doi: 10.4070/kcj.2012.42.4.231. Epub 2012 Apr 26.

Neuronal T-type calcium channels: what's new? Iftinca: T-type channel regulation.

J Med Life. 2011 May 15;4(2):126-38. Epub 2011 May 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验